New Drug Application 2022

Pharmaceutical Investing

Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin

Markets
TSX	20058.08	+84.86
TSXV	586.38	+2.44
DOW	33898.19	+300.27
S&P 500	3971.56	+37.64
NASD	11099.63	+141.08
ASX	7229.40	-61.90

Markets

TSX

20058.08

+84.86

TSXV

586.38

+2.44

DOW

33898.19

+300.27

S&P 500

3971.56

+37.64

NASD

11099.63

+141.08

ASX

7229.40

-61.90

Commodities
Gold	1794.08	+7.02
Silver	23.19	+0.47
Copper	3.89	+0.03
Palladium	1921.78	+79.09
Platinum	1013.00	+8.01
Oil	72.94	+0.93
Heating Oil	2.79	+0.01
Natural Gas	5.87	+0.15

Commodities

Gold

1794.08

+7.02

Silver

23.19

+0.47

Copper

3.89

+0.03

Palladium

1921.78

+79.09

Platinum

1013.00

+8.01

Oil

72.94

+0.93

Heating Oil

2.79

+0.01

Natural Gas

5.87

+0.15

Appia Announces Final Closing of Non-Brokered Private Placement Financing For a Total of $3,666,000

Investing News NetworkYour trusted source for investing success

new drug application 2022

Nabriva Notches First FDA Nod for Pneumonia Treatment

RedHill Biopharma Receives FDA Acceptance for New Drug Application of Talicia

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch,

Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam to Treat Moderate-to-Severe Acne

Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin

GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease

Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO

Adamis Submits NDA for New Product

Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe

BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin

Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053)

IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT

MARKETS

COMMODITIES

DOWNLOAD FREE REPORTS

Updated! Download Your FREE 2022 Energy Outlook Report.

NEW! Download Your 2022 Oil & Gas Outlook Report.

NEW! Download Your 2022 Industrial Metals Outlook Report.

Free! Download Your FREE 2022 Base Metals Outlook Report [Updated Nov 3]

NEW! Download Your FREE 2022 Diamond Outlook Report

NEW! Download Our FREE 2022 Gaming Outlook Report. [Updated Aug 12]

FREE 2022 Blockchain Investor Report [Updated Aug 5]

Gold vs Bitcoin – Dogfight or Detente?

Start Here – Investing in Cleantech

Biotech Investing: Top Biotech ETFS, Stocks, Future Prospects

NEW! Download Your FREE 2022 Pharmaceuticals Outlook Report.

FREE 2022 Psychedelics Investor Report [Updated Aug 5]

Start Here – Investing in Pharma

Start Here – Investing in Genetics

BROWSE COMPANIES BY SECTOR

Featured Stocks

Valore Metals

Blue Star Helium

Bold Ventures

Slave Lake Zinc

Ultra Lithium

Redstone Resources